13G Filing: Sabby Capital and Bioamber Inc. (BIOA)
Bioamber Inc. (NYSE:BIOA): Hal Mintz's Sabby Capital filed an amended 13D.
You can check out Sabby Capital's latest holdings and filings here.
Bioage Labs Inc. (BIOA)
Market is closed
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 450,000 | 1,629,529 | 2024-09-27 | Filing | ||
| $18.00 | 900,000 | 900,000 | 2024-09-27 | Filing | ||
| $18.00 | 400,000 | 1,710,589 | 2024-09-27 | Filing | ||
| $18.00 | 26,497 | 26,497 | 2024-09-27 | Filing | ||
| $18.00 | 21,814 | 21,814 | 2024-09-27 | Filing |
News See All
Bioamber Inc (BIOA): How It Stacks Up Against Its Peers
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
What's the Deal With These Stocks Getting Pounded?
It's been a Friday to forget for many bullish investors as the NASDAQ index opened in the red and continues to decline in late morning trading as valuation worries and concerns about the global economy...
Is Bioamber Inc (BIOA) a Good Long-Term Investment?
Sustainable chemicals company Bioamber Inc (NYSE:BIOA) had a relatively quiet IPO in May.
Billionaire Hedge Funds
